Member Info for Hartlebury

Wilson, I remember reading reports a few months ago estimating vaccine resistance generally at around 40% in France, the comments made by Macron won’t have helped. It seems to be a cultural thing there (libertarian stance perhaps?) but I know they’ve had big problems with measles outbreaks in recent years for example, as a result of the anti vax sentiment.

Paul we do know that the request has been refused (or not yet granted), how else to interpret the rns’s released about this?

It looks like they are doing just that Porky, Pillar 1 testing capacity continues to creep up in apparent increments of around 500 every couple of days and the number of tests performed is also increasing. https://coronavirus.data.gov.uk/details/testing

Donno I agree that line was a f*** up but how do you suggest they take it back without giving concrete info, which could only come with confirmation of contracts? Anything else from GM would sound woolly and unconvincing, I think the broker notes being reissued is an attempt to emphasise the estimates they are currently comfortable with

It’s not true that we don’t have any idea at all of future income- unless the company updates us otherwise then the broker notes provide all the forecasts we are going to get...GM will have agreed that they are reasonable assumptions for the analysts to make and given that this will form the basis of ‘expectations in the market’, if something happens to cause much deviation above or below them then an rns would be required to adjust accordingly.

@Novice the FCA will restore the shares to trading when they are satisfied that there is no threat to an orderly market/protection of shareholders no longer required. AZ could request to keep suspension in place longer but would have to provide evidence that there are grounds that would cause FCA to worry about orderly market etc.

Dartron I thought the same thing re GDR, made me wonder about price point (GDR seems high to me at apparent £10-£15) and also I’ve been unable to find out how many BC high throughput platforms there are already in use (although they are a massive company, in context of PCR they don’t seem to get mentioned along with the likes of TF/Abbot/HoLogic), so we may steal a march there, being open platform and already used in Lighthouse Labs for example.

Exactly Parm, FCA regulate LSE listed companies with regard to their compliance with the FCA handbook (listing rules), not it’s business activities. The only time they regulate business activities is where a financial service provider is FCA listed and has been approved as a provider.

It’s not a regulated as a provider of financial services KingJ, it is regulated as a listed company, why else would fca have anything to do with it?!

The FCA has no authority in UAE countries...what does that have to do with anything? The company is regulated by the FCA as a company listed on the LSE - the shares are suspended from trading but the business operations are unaffected (in all geographies).

Just pondering the ‘opening up the economy’ situation with LFT’s...providing antibodies mean reduced transmission (as hoped but not yet proven), in my mind an antibody LFT makes much more sense longer term for lower risk situations such as clubs and festivals than an antigen one. Antigen only confirms you don’t have infection at that point in time, very regular testing would be necessary to uphold the already limited benefit? Surely antibodies would need much less regular testing (monthly?) and an app to support your status would be more useful than trying to time antigen LFT before an event? And avoid the vaccine passport issue....

Interesting article Johnny, UK seemed to be going down that path in Q2 last year with various companies touting their test at home antibody test kits ‘coming soon’ but the brakes were sharply applied!

Re tax, until a cash gain is actually realised I’m not sure how it could be liable for tax-not an expert though!

The latter is only true in terms of dilution though, it doesn’t affect value of what you hold. As to whether a cash sale is preferable, that would depend on your view of the potential of the spin off company and attitude to risk. You would of course have the option to sell your shares (possibly after a lock in period).

EKF is currrently doing this with Trellus and as I understand it, 40% (as an example) of Trellus is held by EKF and that has been passed on to shareholders already, the float and fundraising is (hopefully) happening soon and that will put actual value on Trellus pre/post placing, so it’s not as if there’s an ascribed value at the point of spin off that is then altered if that makes sense? You’d hope that another fundraising wouldn’t be necessary in the near term.

I thought it was incredible that, according to one article featuring Sharon P, the UK sequencing efforts have provided 50% of the GLOBAL sequencing database of covid variants - and if, as it appears, NCYT are working hand in hand with that group of scientists running the sequencing programme, it bodes extremely well indeed.

Good article Wilson, would be amazing if NCYT was positioning itself as a player in this market.

Really useful discourse today, thanks guys. Sorry for your situation Xerxes, good real world example though.

Even scarier!

Or...it wasn’t a c**k up, they did it intentionally? Given the delayed schedule we are all aware of, I suspect the accounts that would have been due by end of Jan would not have painted a pretty picture. May not have helped negotiations with funders, wouldn’t do SP any favours. Changing the reference date again bought an extra three months (five as FCA are relaxing rules for covid) for SYME to put out an audited full year of results, during which funding could hopefully get sorted and make the whole picture completely different. Technically they haven’t broken any rules by changing the date like this but the FCA wouldn’t be impressed with this because the principle they work on is ensuring full information is in the market on a timely basis for the protection of shareholders. I think that this, coupled with allegations/complaints have triggered the checks that are being done. So in a sense the move backfired because I don’t think syme were expecting such a long suspension, however it could end up working in their (and our) favour if the time in suspension is used to get funder in place.